Testicular Abnormality in a Young Man
November 1st 2007A 21-year-old man presents with a "swelling" in the testicle that he first noticed about 1 month earlier while showering. He does not recall any previous scrotal tenderness; because he has been frequently palpating the lesion, he cannot say for certain whether it is currently tender.
Polypharmacy in Elderly Patients: Practical Tips to Avoid Adverse Effects and Interactions
November 1st 2007An 81-year-old woman with a history of moderate Alzheimer dementia, depression, coronary artery disease, hypertension, and type 2 diabetes mellitus was accompanied to the office by her son for a routine follow-up appointment.
New Horizons in Guillain-Barré Treatment
November 1st 2007The Dutch Guillain-Barré Study Group found that intravenous immunoglobulin and therapeutic plasma exchange were equally effective in the treatment of GBS. The Plasma Exchange/Sandoglobulin Guillain-Barré; Syndrome Trial Group demonstrated that therapeutic plasma exchange alone, intravenous immunoglobulin alone, and therapeutic plasma exchange immediately followed by a course of intravenous immunoglobulin were all equally effective.
Does the Brain Have to Pay for the Heart's Procedures?
November 1st 2007The development of more sophisticated testing modalities now permits the identification of coronary artery narrowing in asymptomatic adults. The images obtained in these studies provide potential targets for intervention-based therapy.
Pyoderma Gangrenosum on Both Legs of a 62-Year-Old Woman
November 1st 2007Worsening painful ulcers on both legs prompted a 62-year-old woman to seek medical attention. She had a history of rheumatoid arthritis (RA), demonstrated by the markedly deformed interphalangeal joints in her thumbs (A), and scleroderma-polymyositis overlap syndrome.
Diabetes: A Primer on New Drug Options
November 1st 2007Over the past 20 years, the treatment armamentarium for diabetes has greatly expanded: 8 different classes of non-insulin drugs and 8 different types of insulin are now available. The newer classes of agents include disaccharidase inhibitors, thiazolidinediones, meglitinides, glucagonlike peptide analogs, and dipeptidyl peptidase IV inhibitors.